(CercleFinance.com) – Mauna Kea shares lost ground in sustained volumes on Friday on the Paris Stock Exchange, the medical device manufacturer having unveiled a drop in turnover over the first nine months yesterday evening of the year.
The mini-probe laser endomicroscopy specialist posted total sales of 4.8 million euros as of September 30, down 5% year-on-year.
Its CEO, Sacha Loiseau, evokes “satisfactory” results in view of the difficult operating environment and the reallocation of resources which followed the strategic reorganization of the company, initiated at the end of 2021.
He points out in particular that sales growth in the United States reached 23% over the first nine months of the financial year.
In the third quarter, the total turnover however fell by 20% to 1.42 million euros, even if the company recalls that the sales of systems are “by nature difficult to predict” over this period.
At 2:30 p.m., the title fell by 8.7% in volumes already representing 1.5 times their daily average for the last four sessions. At the same time, the CAC Mid & Small yielded 1.4%.